GSK Plans Cervarix NDA Filing Two Years Ahead Of Schedule
A European filing is expected by 2006. GSK is still in discussions with FDA on surrogate endpoints, which could determine whether the U.S. filing will be in 2006 or 2007.
A European filing is expected by 2006. GSK is still in discussions with FDA on surrogate endpoints, which could determine whether the U.S. filing will be in 2006 or 2007.